Status In progress
Process MTA
ID number 3957

Project Team

Project lead Donna Barnes

Email enquiries

Evidence Review Group / Assessment Group Warwick Evidence, Warwick Medical School, University of Warwick

Consultees

Companies sponsors Air Liquide Healthcare Ltd
  CamDiab Ltd
  DexCom International Ltd
  Medtronic Ltd
  Tandem Diabetes Care, Inc
Others Department of Health and Social Care
  NHS England
  Welsh Government
Patient carer groups Diabetes UK
  Juvenile Diabetes Research Foundation (JDRF)
Professional groups Diabetes Technology Network - UK
  Royal College of Physicians
  The Royal College of Pathologists

Commentators

Assessment group Warwick Evidence
Comparator companies Abbott Diabetes Care
  Insulet International Ltd
General commentators All Wales Therapeutics and Toxicology Centre
  British National Formulary
  Department of Health, Social Services and Public Safety for Northern Ireland
  Healthcare Improvement Scotland
  Medicines and Healthcare Products Regulatory Agency
  Scottish Medicines Consortium
  Welsh Health Specialised Services Committee

Timeline

Key events during the development of the guidance:

Date Update
06 April 2021 In progress. This topic began as a diagnostic assessment and became a multiple technology appraisal during scoping.
18 December 2020 Invitation to participate

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance